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Evidence is presented that glutamate binding to rat brain synaptic plasma membranes measured in Cl-- and Na+-free 
but CaZ+-supplemented buffers is partly due to uptake of glutamate into resealed membrane vesicles, An intravesicular 
volume of 7.9 $/mg protein was measured. Caz+ -induced glutamate binding to synaptic plasma membranes was found 
to be sensitive to low temperatures as well as to an increase in osmolarity and was abolished by short pulses of ultrasonica- 
tion. None of several glutamate receptor agonists tested discriminated between basal and Caz+-induced binding, but 4 
out of 5 glutamate uptake inhibitors did. The Caz+-induced increase in glutamate binding was the same irrespective of 
whether calcium acetate, calcium sulfate or calcium gluconate in either Tris-acetate of Tris-citrate buffer was used. 
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1. INTRODUCTION 
Triggered by the pioneering work of Pin et al. 
[l] in 1984, several recent publications questioned 
the long-held opinion that Cl--dependent 
glutamate binding to brain synaptic plasma mem- 
branes (SPM) really reflects postsynaptic receptor 
binding [2-51. Instead, these authors accumulated 
a convincing body of evidence suggesting that this 
‘receptor binding’ actually represents uptake into 
resealed membrane vesicles. This new form of 
glutamate transport was found to differ in many 
features from the long-established Na+-dependent 
uptake system [ 1,5]. 
For our work on postsynaptic glutamate recep- 
tors these reports were the signal to change our 
standard buffer system from Tris-chloride to Tris- 
acetate in order to avoid uptake artifacts. Addi- 
tionally, we set out to check whether we could 
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detect any indications for glutamate uptake when 
employing the chloride-free Tris-acetate buffer 
system. To our surprise, we found a Ca2+-induced 
‘binding’ stimulation, usually of around 140%) 
which exhibited all properties of a transport 
phenomenon but was absolutely independent of 
either Cl- or Na+ added exogenously. The pur- 
pose of this paper is to describe some properties of 
this novel uptake mechanism. Furthermore, we 
wish to point out the necessity to reconsider 
carefully receptor binding data measured in the 
presence of calcium. 
2. MATERIALS AND METHODS 
2.1. Membrane preparations 
Crude cortex SPM from 3-month-old male Wistar rats were 
obtained according to Enna and Snyder 161 while purified SPM 
were prepared by the procedure of Jones and Matus [7]. All 
final membranes were washed 3 x with 50 mM Tris-acetate, pH 
7.1 at 37’C (Tris-Ac), and were stored frozen in Tris-Ac at 
- 80°C for up to 2 months without significant loss of any bind- 
ing properties. 
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2.2. Glutamate-binding assay 
L-[3H]Glutamate binding to SPM was measured by a filtra- 
tion assay. Briefly, 100 pl SPM (= 70-100 ,ug protein) were in- 
cubated in Tris-Ac at 37°C for 60 min in a total volume of 
300,ul with L-[3H]glutamate (Amersham, 53 Ci/mmol) added 
to give a final concentration of 50 nM. According to the 
specific experimental requirements, salts and/or glutamate- 
binding inhibitors had been added from IO-fold concentrated 
stock solutions prior to the membranes. Addition of ice-cold 
Tris-Ac and rapid filtration onto nitrocellulose filters 
(Schleicher & Schuell BASS) terminated the incubation period. 
Filters were washed once with ice-cold Tris-Ac, solubilized in 
scintillator (ACS, Amersham) and counted. Specific binding 
was calculated as the difference between total binding and 
unspecific binding which was measured in the presence of a 
2000-fold excess (100 PM) of unlabeled L-glutamate. All deter- 
minations were made in triplicate. Standard errors were less 
than 10%. All inhibitors used were from Sigma (St. Louis) ex- 
cept DL-three-hydroxyaspartate, which was from Calbiochem 
(San Diego). 
2.3. Estimation of intravesicular space 
lntravesicular volumes of resealed vesicles in SPM prepara- 
tions were measured utilizing the differential distribution of a 
membrane-permeable (3Hz0) and a membrane-impermeable 
([%Z]inulin) tracer according to Rudnick [S]. The enrichment 
of ‘Hz0 over [%]inulin in the membrane pellet relative to the 
control value of the membrane supernatant provided a measure 
of the intravesicular space. 
Protein was estimated according to Peterson [9]. 
3. RESULTS 
3.1. Characterization of basal and Cl?+-induced 
binding 
Basal [3H]Glu binding in Tris-Ac buffer at 37°C 
saturated within 45 min, was linearly dependent on 
the protein concentration and exhibited biphasic 
kinetics (see fig.l), with a high-affinity site (Kd = 
838 f 99 nM, b,,, = 4.5 f 0.5 pmol/mg protein) 
and a low-affinity site (& = 1954 f 245 nM, 
b max = 8.8 f 1.3 pmol/mg protein). Upon addi- 
tion of 5 mM calcium acetate, binding was in- 
creased by an average of 138%, from 229 f 6 to 
544 f 8 fmol/mg protein (mean of 32 determina- 
tions f SE using the standard binding assay). This 
increase in binding was clearly due to an increase 
in the number of low-affinity binding sites, leaving 
their affinity unchanged (& = 1850 f 87, b,,, = 
23.0 + 1 .l, see fig.1). High-affinity sites were not 
detectable in the presence of calcium. Increased 
binding was elicited by calcium concentrations 
ranging from 0.5 to 10 mM (not shown). 
Ca’+-induced binding was temperature sensitive -
no significant increase could be produced at 0°C 
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Fig.1. Saturation curves (inset) and Scatchard plots of L- 
glutamate binding to crude rat cortex SPM in the absence (0) 
or presence (x) of 5 mM calcium acetate. Binding was assayed 
at 37°C for 60 min (see section 2) with glutamate concentrations 
ranging from 5 to 6640 nM. Data are means of 3 determina- 
tions, all done in triplicate. 
(140 + 14 and 164 & 14 fmol/mg protein with and 
without Ca*+, respectively; mean of 10 determina- 
tions f SE). Preincubation of SPM at 37°C 
followed by extensive washings did not reduce 
Ca*+-induced binding stimulation, rendering 
unlikely the possibility that contaminating Cl- in- 
teracting with Ca’+ could be responsible for the in- 
crease in binding. 
These data led us to the speculation that the 
Ca*+-induced elevation of binding might represent 
glutamate uptake into resealed membrane vesicles 
rather than receptor binding. 
3.2. Determination of in travesicular space in SPA4 
preparations 
Membrane vesicles, a prerequisite for any form 
of uptake, have been reported to exist in SPM 
preparations [1,3,7]. In fact, procedures used to 
prepare SPM are very similar to those designed to 
produce vesicles for uptake experiments [8,10-121. 
We therefore measured the intravesicular space in 
our SPM preparations. We found 7.9 f 0.3 pl/mg 
protein (mean of 12 determinations f SE), which 
is almost identical with the volume reported for a 
vesicle preparation from rat brain membranes [lo]. 
Incubation of the SPM with 5 mM Ca*+ did not in- 
crease the intravesicular space (6.5 + 0.2 pl/mg). 
Thus, uptake cannot be due to an increase in vesi- 
cle size, as one might speculate in view of the 
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known property of Ca*+ to enhance fusion of pro- 
teoliposomes [13]. Incubation with 0.3 M sucrose 
or 5 s of ultrasonication with a tip sonicator (Bran- 
son, microtip, setting 3) reduced the intravesicular 
volume by about 50070, while incubation of SPM 
with 0.5% Triton X-100 abolished it completely. 
3.3. Influence of osmolarity and ultrasonication 
on &‘-induced binding 
To test our uptake hypothesis, we assayed both 
basal as well as Ca*+-induced binding, in the 
presence of increasing amounts of sucrose, in 
order to reduce the intravesicular space by osmotic 
compression of vesicles [I ,9,10]. As can be seen in 
fig.2, basal binding is hardly affected by this treat- 
ment whereas Ca*+-induced binding is abolished 
completely. Preincubation of SPM with 0.9 M 
sucrose followed by 3 x washing with Tric-Ac did 
not return Ca*+-induced binding to sucrose-free 
control levels, indicating that it was not an in- 
hibitory influence of the sucrose itself that abolish- 
ed the Ca*+-induced binding. 
Ultrasonication of SPM for 5 s, either prior to 
the [3H]glutamate incubation period or immediate- 
ly afterwards, led to a substantial suppression of 
Ca*+-induced binding, whereas basal binding was 
not significantly affected under these conditions. 
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Fig.2. Influence of increasing concentrations of sucrose on L- 
[‘H]glutamate binding to crude rat cortex SPM, measured at 
37°C in the absence (0) or presence (x) of 5 mM calcium 
acetate. SPM were preincubated for 25 min with the indicated 
sucrose concentrations, then L-[‘HIglutamate was added and 
incubation continued for another 60 min. Data are means of 3 
determinations, done in triplicate. SE of all data was less than 
15%. 
Without sonication we found a basal binding of 
243 + 26 fmol/mg, which was increased in the 
presence of 5 mM calcium to 603 + 46 fmol/mg, 
whereas after sonication we measured 187 f 18 
and 295 * 31 fmol/mg, respectively (means of 2 
determinations + SE). This finding is in agree- 
ment with the marked reduction by ultrasonication 
of intravesicular space, as reported above, pro- 
viding additional evidence for an uptake process 
being responsible for the Ca*+-induced elevation 
of binding. 
3.4. Pharmacology and influence of anions on 
&+-induced binding 
In order to characterize and compare the phar- 
macology of basal and Ca*+-induced binding sites 
we tested the inhibitory action of several glutamate 
receptor agonists and some known glutamate up- 
take inhibitors (see table 1). Out of all compounds 
Table 1 
Comparison of inhibition of basal and Ca”-induced glutamate 
binding by receptor agonists and uptake inhibitors 
Inhibition of Inhibition of 
basal binding Ca *‘-induced binding 
L-Glutamate 
L-Aspartate 
D-Aspartate 
L-Cysteinesulfinate 
L-Homocysteinate 
lbotenate 
Quisqualate 
N-Methyl-D-aspartate 
Kainate 
2-Amino4phosphono- 
butyrate 
DL-threo-Hydroxy- 
aspartate 
DL-Aspartate-fl- 
hydroxamate 
SITS (4-acetamido-4’- 
isothiocyanato- 
stilbene-2,2’- 
disulfonate) 
100 
93 f 12 
25* 13 
6Ok 8 
72k 19 
108 + 19 
llO+ 8 
8& 10 
- 16 + 10 
24t 15 
6+ 8 
4f 19 
42k 11 
100 
74+ 9 
9& 9 
63k 11 
107 + 11 
99* 10 
84? 8 
ilk 8 
4* 13 
67* 10 
4Ok 8 
50t 10 
79* 8 
Potency of inhibitors (all tested at 100 PM) was assayed in the 
absence or presence of 1 mM calcium acetate as described in 
section 2, using crude rat cortex SPM. Inhibitor-displaceable 
glutamate binding in the absence of calcium (= basal binding) 
was subtracted from inhibitor-displaceable binding in the 
presence of calcium to obtain Ca ‘+-induced binding. All data 
are given in percent, inhibition by L-glutamate being set to 
100%. Data are means t SE of 2 determinations done in 
triplicate 
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tested, only 2-amino-4-phosphonobutyric acid, 
DL-three-hydroxyaspartate, DL-aspartate-P-hy- 
droxamate and SITS (bacetamido-4’-isothio- 
cyanatostilbene-2,2’-disulfonic a id) discriminated 
between basal and Ca2+-induced binding, in effec- 
tively inhibiting the latter while leaving basal bind- 
ing unchanged or much less affected. This finding 
is interesting, since the latter 4 compounds have 
been reported to be inhibitors of glutamate uptake 
[2,14-161. However, another inhibitor of Na+- as 
well as Cl--dependent glutamate uptake, D- 
aspartate [l, 161, did not inhibit Ca’+-induced 
binding. 
We observed the Ca2+-induced increase in 
glutamate binding not only in crude SPM [6] but 
also in sucrose gradient-purified SPM [7], and in 
Tris-Ac buffer as well as Tris-citrate. Furthermore, 
binding stimulation was the same irrespective of 
whether we used calcium acetate, calcium 
gluconate or calcium sulfate. Calcium salts with 
membrane-permeable counter anions (Cl-, Br-, 
NOi) gave an additional, sucrose-sensitive lo-fold 
binding stimulation, indicative of activation of the 
recently described [l-5] Cl--dependent/Na+-in- 
dependent uptake system (not shown). 
4. DISCUSSION 
From the data presented above we conclude that 
Cazc-induced stimulation of glutamate binding to 
SPM in the absence of Cl- and Na+ represents up- 
take into resealed membrane vesicles. This view is 
supported by the following observations: 
(i) No Ca2+ induction of binding is found at 0°C; 
(ii) Ca2+ -induced binding, as opposed to basal 
binding, is sensitive to an increase in osmolarity; 
(iii) Ca’+-induced binding, as opposed to basal 
binding, is abolished by short ultrasonication; 
(iv) The intravesicular volume of the SPM 
preparations used is not negligible but represents a
volume comparable to that found in vesicle 
preparations; 
(v) Several known glutamate uptake inhibitors 
abolish Ca2+-induced binding, as opposed to basal 
binding; 
(vi) Dissociation of Ca2+-induced binding in the 
presence of a 20000-fold excess of unlabeled 
glutamate proceeds with a half-life of about 30 min 
(not shown), which is at least 30-times lower than 
reported for postsynaptic receptor binding [ 161. 
Several glutamate transport mechanisms in 
brain tissue have been described. Among these, 
Na+-dependent uptake is the most prominent. 
However, participation of this type of uptake can 
be excluded because it is absolutely dependent on 
Na+ and has a different pharmacology. Notably, it 
is not inhibited by quisqualate [17], whereas 
Ca2+-induced uptake is almost completely abolish- 
ed by quisqualate. 
The glutamate uptake process found in synaptic 
vesicles [18] differs from Ca’+-induced uptake in 
being Ca2+ -independent, not inhibitable by quis- 
qualate and in having a much lower affinity (& = 
1.6 mM). 
Mitochondrial glutamate uptake [19] is also 
unrelated to the Ca2+-induced uptake, having a 
lOOO-fold lower affinity (& = 4 mM) concomitant 
with a much higher binding site density (bmax = 
23 nmol/min per mg, measured at 25°C). 
The recently described [l-5] Cl--dependent/ 
Na+-independent uptake system usually is address- 
ed as ‘Cl-/Ca’+-dependent binding’ [ 1,2], reflec- 
ting the observation that Ca2+ enhances 
Cl--dependent uptake. However, it has been com- 
pletely overlooked that calcium itself induces con- 
siderable uptake even in the absence of Cl-. 
Whether the type of uptake described here 
represents a novel mechanism of glutamate trans- 
port or is just a special case of the Cl--dependent 
process is not clear at present. Published affinity 
data for the Cl--dependent uptake process vary 
broadly, ranging from Kd = 0.2 PM to 5 PM [2,4]. 
Thus, comparison with the Ca’+-induced uptake is 
difficult. The pharmacology shows some 
similarities, although the lack of inhibition by D- 
aspartate in the case of Cazf-induced uptake is a 
notable difference. To clarify this question, work 
along these lines is in progress. 
The results discussed above strongly suggest hat 
glutamate receptor binding data obtained in 
Cl-INa+-free buffers in the presence of CaZf at 
assay temperatures above 0°C should be urgently 
reevaluated. 
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